What is CHEK's earnings growth forecast for 2025-2025?
(NASDAQ: CHEK) Check Cap's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Check Cap's earnings in 2025 is -$25,149,000.
In 2025, CHEK is forecast to generate -$14,323,018 in earnings, with the lowest earnings forecast at -$13,761,331 and the highest earnings forecast at -$14,744,283.
What is CHEK's revenue growth forecast for 2025-2025?
(NASDAQ: CHEK) Check Cap's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Check Cap's revenue in 2025 is $0.
In 2025, CHEK is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is CHEK's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: CHEK) forecast ROA is -3,799.21%, which is lower than the forecast US Diagnostics & Research industry average of 9.07%.
What is CHEK's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: CHEK) Check Cap's current Earnings Per Share (EPS) is -$4.30. In 2025, CHEK's EPS is forecast to hit -$2.45 (min: -$2.35, max: -$2.52).
What is CHEK's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: CHEK) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.